LRP1B loss was significantly increased in CSCs and for the first time linked to short-term prognosis (1-year survival), both at genomic and transcriptomic level, confirming its pivotal role in bladder cancer tumorigenesis. Here, LRP1B is linked to urinary bladder carcinoma.